ABSTRACT
BACKGROUND AND OBJECTIVES: Melanoma differentiation-associated gene 5 antibody (anti-MDA5) in dermatomyositis (DM) is associated with rapidly progressive interstitial lung disease and poor prognosis. Early diagnosis is key to improving the prognosis of these patients. The aim was to confirm cutaneous characteristics in patients with anti-MDA5 dermatomyositis and to explore new diagnostic markers for the presence of anti-MDA5 (anti-MDA5+ ). PATIENTS AND METHODS: A multicenter cross-sectional retrospective cohort study of 124 patients diagnosed with DM, of which 37 were anti-MDA5+ . Demographic data, laboratory data, and clinical manifestations were collected. RESULTS: Anti-MDA5+ DM is characterized by a distinct mucocutaneous phenotype that includes oral lesions, alopecia, mechanic's hands, palmar and dorsal papules, palmar erythema, vasculopathy, and skin ulceration. We found vasculopathy and digit tip involvement very frequently in anti-MDA5+ patients (p <0.001), being a diagnostic marker of anti-MDA5+ (OR, 12.355; 95% CI 2.850-79.263; p = 0.012 and OR, 7.447; 95% CI 2.103-46.718; p = 0.004, respectively). The presence of ulcers deserves special mention, especially in anti-MDA5+ patients, because in our cohort, up to 97% of the anti-MDA5+ patients had ulcers. CONCLUSIONS: In patients with suspected DM with digit tip involvement or vasculopathy, the presence of anti-MDA5 antibodies must be ruled out, as it may be a clinical predictor.
Subject(s)
Dermatomyositis , Humans , Retrospective Studies , Interferon-Induced Helicase, IFIH1 , Ulcer , Cross-Sectional Studies , Autoantibodies , PrognosisABSTRACT
BACKGROUND: Although subclinical enthesopathy is a well-established diagnostic criterion for psoriatic arthritis (PsA), it is frequently overlooked, as many patients are asymptomatic. The possibility of finding a clinical clue predicting enthesopathy would help clinicians establish an early diagnosis of PsA. MATERIAL AND METHODS: A prospective single-center study of a total of 90 patients with psoriasis was conducted to assess the presence of entheseal abnormalities as detected by ultrasound, and to determine any correlation with nail involvement. RESULTS: Entheseal abnormalities were found in 23 patients (25.5 %), 19 (82.6 %) of whom showed nail involvement, whereas four (17.4 %) individuals did not. Enthesopathy was present in 31.1 % (19/61) of patients with onychopathy compared to 13.8 % (4/29) of those without nail involvement (p = 0.07). There was a significant correlation between target NAPSI score and evidence of enthesopathy. In addition, the number of nails affected also showed a significant correlation with the presence of enthesopathy (p = 0.035). CONCLUSIONS: Clinical evidence of onychopathy may be the clue to an early diagnosis of enthesopathy in psoriasis patients.
Subject(s)
Enthesopathy/diagnostic imaging , Enthesopathy/epidemiology , Nail Diseases/diagnosis , Nail Diseases/epidemiology , Psoriasis/diagnosis , Psoriasis/epidemiology , Age Distribution , Comorbidity , Early Diagnosis , Female , Humans , Male , Middle Aged , Prevalence , Prognosis , Reproducibility of Results , Risk Assessment/methods , Risk Factors , Sensitivity and Specificity , Sex Distribution , Spain/epidemiologyABSTRACT
HINTERGRUND: Obwohl subklinische Enthesiopathie ein gut etabliertes diagnostisches Merkmal der Psoriasisarthritis (PsA) ist, wird sie häufig übersehen, da viele Patienten asymptomatisch sind. Gäbe es klinische Hinweise auf das Vorliegen einer Enthesiopathie, würde dies den Klinikern die Möglichkeit eröffnen, eine PsA frühzeitig zu diagnostizieren. MATERIAL UND METHODEN: Es wurde eine monozentrische prospektive Studie mit insgesamt 90 Psoriasis-Patienten durchgeführt, um mittels Ultraschall das Vorliegen von Enthesenanomalien zu untersuchen und eine Korrelation mit dem Befall der Nägel festzustellen. ERGEBNISSE: Enthesenanomalien wurden bei 23 Patienten (25,5 %) gefunden, von denen 19 (82,6 %) Nagelbefall aufwiesen. Bei 4 Patienten waren die Nägel nicht betroffen. Enthesiopathie lag bei 31,1 % (19/61) der Patienten mit Onychopathie vor, von den Patienten ohne Nagelbefall litten nur 13,8 % (4/29) an Enthesiopathie (p = 0,07). Zwischen dem Target-NAPSI-Score und dem Vorliegen einer Enthesiopathie bestand eine signifikante Korrelation. Eine signifikante Korrelation bestand darüber hinaus auch zwischen dem Vorliegen einer Enthesiopathie und der Anzahl der betroffenen Nägel (p = 0,035). SCHLUSSFOLGERUNGEN: Klinische Belege für eine Onychopathie können der Schlüssel für die frühe Diagnose einer Enthesiopathie bei Psoriasis-Patienten sein.
ABSTRACT
Systemic inflammation or insulin resistance drive atherosclerosis. However, they are difficult to capture for assessing cardiovascular risk in clinical settings. The monocyte-to-high-density lipoprotein ratio (MHR) is an accessible biomarker that integrates inflammatory and metabolic information and has been associated with poorer cardiovascular outcomes. Our aim was to evaluate the association of MHR with the presence of subclinical atherosclerosis in patients with psoriasis. The study involved a European and an American cohort including 405 patients with the disease. Subclinical atherosclerosis was assessed by coronary computed tomography angiography. First, MHR correlated with insulin resistance through homeostatic model assessment for insulin resistance, with high-sensitivity CRP and with 18F-fluorodeoxyglucose uptake in spleen, liver, and bone marrow by positron emission tomography/computed tomography. MHR was associated with both the presence of coronary plaques >50% of the artery lumen and noncalcified coronary burden, beyond traditional cardiovascular risk factors (P < .05). In a noncalcified coronary burden prediction model accounting for cardiovascular risk factors, statins, and biologic treatment, MHR added value (area under the curve base model = 0.72 vs area under the curve base model plus MHR = 0.76, P = .04) within the American cohort. These results suggests that MHR may detect patients with psoriasis who have subclinical burden of cardiovascular disease and warrant more aggressive measures to reduce lifetime adverse cardiovascular outcomes.
ABSTRACT
Eosinophilic fasciitis (EF) is a rare entity characterized by symmetrical and painful thickness and induration of the skin, especially localized on forearms and thorax and generally accompanied by eosinophilia. Although several reports indicate the relationship between EF and hematological disorders such as aplastic anemia, polycythemia vera, or myelomonocytic leukemia, the association with lymphomas is extremely rare. Only a few cases of EF have been previously described preceding or concomitant to the Hodgkin disease, peripheral T-cell lymphoma, B-cell lymphoma, and mycosis fungoides. We report for the first time a 76-year-old man with an EF associated with a peripheral T-cell lymphoma not otherwise specified. We review the relationship between both conditions. In conclusion, we present a unique case of EF as a manifestation of a T-cell lymphoma not otherwise specified. The present case demonstrates the importance of clinical and radiological studies in those cases of EF to rule out a visceral, lymph node, or cutaneous lymphoma.
Subject(s)
Eosinophilia/diagnosis , Fasciitis/diagnosis , Lymphoma, T-Cell, Cutaneous/diagnosis , Paraneoplastic Syndromes/diagnosis , Skin Neoplasms/diagnosis , Skin/pathology , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor/analysis , Biopsy , Eosinophilia/immunology , Eosinophilia/pathology , Fasciitis/immunology , Fasciitis/pathology , Humans , Immunohistochemistry , Lymphoma, T-Cell, Cutaneous/drug therapy , Lymphoma, T-Cell, Cutaneous/immunology , Lymphoma, T-Cell, Cutaneous/pathology , Male , Paraneoplastic Syndromes/immunology , Paraneoplastic Syndromes/pathology , Predictive Value of Tests , Skin/immunology , Skin Neoplasms/drug therapy , Skin Neoplasms/immunology , Skin Neoplasms/pathology , Treatment OutcomeABSTRACT
Psoriasis is a chronic and inflammatory disease that affects the skin and joints and is associated with multiple comorbidities and cardiovascular risk factors. Consequently, patients with psoriasis have an increased risk of cardiovascular diseases such as atherosclerosis, a chronic pathology that shares common inflammatory and immune-response mechanisms with psoriasis, including vascular inflammation and complement activation. To better understand the relationship between atherosclerosis and psoriasis, a proteomics study followed by a bioinformatics analysis was carried out, with a subsequent validation step using ELISA and western blotting. When the plasma from patients with psoriasis alone was compared with that from patients with psoriasis and atherosclerosis, 31 proteins of interest related to the complement system and oxygen transport were identified. After the validation phase, 11 proteins appeared to define the presence of subclinical atherosclerosis in patients with psoriasis, indicating the importance of complement cascades in the development of atherosclerotic plaques in individuals with psoriasis. These results are a step forward in understanding the pathological pathways implicated in the cardiovascular risk associated with this population, which may represent an interesting starting point for developing predictive tools that improve the follow-up of these patients and design more effective therapies.
Subject(s)
Foot Ulcer/etiology , Pigments, Biological/analysis , Pseudomonas Infections/etiology , Pseudomonas aeruginosa/isolation & purification , Acetic Acid/therapeutic use , Anti-Bacterial Agents/therapeutic use , Ciprofloxacin/therapeutic use , Combined Modality Therapy , Dermoscopy , Female , Fluorescence , Foot Ulcer/drug therapy , Foot Ulcer/metabolism , Foot Ulcer/therapy , Humans , Immersion , Levofloxacin/therapeutic use , Middle Aged , Pseudomonas Infections/drug therapy , Pseudomonas Infections/metabolism , Pseudomonas Infections/therapy , Pseudomonas aeruginosa/chemistrySubject(s)
Anemia, Myelophthisic/etiology , Bone Marrow Examination , Melanoma/secondary , Neoplastic Stem Cells/pathology , S100 Proteins/analysis , Aged , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor , Biopsy, Needle , Fatal Outcome , Humans , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/secondary , Male , Melanoma/blood , Melanoma/complications , Melanoma/diagnostic imaging , Melanoma/drug therapy , Neoplastic Stem Cells/chemistry , Splenic Neoplasms/diagnostic imaging , Splenic Neoplasms/secondary , Tomography, X-Ray ComputedSubject(s)
Antiviral Agents/adverse effects , Drug Eruptions/etiology , Hepatitis C, Chronic/drug therapy , Interferon-alpha/adverse effects , Polyethylene Glycols/adverse effects , Skin Ulcer/chemically induced , Amoxicillin-Potassium Clavulanate Combination/therapeutic use , Anti-Bacterial Agents/therapeutic use , Antiviral Agents/administration & dosage , Antiviral Agents/therapeutic use , Debridement , Drug Eruptions/drug therapy , Drug Eruptions/surgery , Drug Therapy, Combination , Female , Humans , Injections, Subcutaneous , Interferon alpha-2 , Interferon-alpha/administration & dosage , Interferon-alpha/therapeutic use , Middle Aged , Necrosis , Polyethylene Glycols/administration & dosage , Polyethylene Glycols/therapeutic use , Recombinant Proteins/administration & dosage , Recombinant Proteins/adverse effects , Recombinant Proteins/therapeutic use , Ribavirin/administration & dosage , Ribavirin/therapeutic use , Skin Ulcer/drug therapy , Skin Ulcer/surgeryABSTRACT
Sarcoidosis is an idiopathic multisystem granulomatous disease that commonly involves the skin in 25% of affected patients. Because lesions assume a vast array of morphologies, a classification dividing them into specific (with presence of typical granulomas in the biopsy) or nonspecific (not containing granulomas) has been proposed. In the first group the variant morpheaform is considered exceptional. We review the cases reported in the literature and describe the possible differential diagnosis. We highlight the importance of recognizing the very atypical presentation of sarcoidosis and its ability to mimic morpheaform or sclerosis diseases in our patients.
Subject(s)
Sarcoidosis/diagnosis , Skin Diseases/diagnosis , Diagnosis, Differential , Granuloma/diagnosis , Granuloma/pathology , Humans , Sarcoidosis/pathology , Sclerosis , Skin Diseases/pathologyABSTRACT
Since Perrinaud in 2006 first described three patients with hemorrhagic bullae in relation to the use of heparins, numerous cases have been published. Currently, this entity has been established as a clearly defined pathology. We review all reported cases, diagnostic features and features that differentiate it from other skin manifestations caused by heparin having a worse prognosis and requiring a precise identification.
Subject(s)
Anticoagulants/adverse effects , Drug Eruptions/etiology , Heparin/adverse effects , Skin Diseases, Vesiculobullous/chemically induced , Diagnosis, Differential , Drug Eruptions/diagnosis , Drug Eruptions/pathology , Drug Eruptions/therapy , Humans , Skin Diseases, Vesiculobullous/diagnosis , Skin Diseases, Vesiculobullous/pathology , Skin Diseases, Vesiculobullous/therapyABSTRACT
No disponible
Subject(s)
Humans , Female , Middle Aged , Foot Ulcer/diagnosis , Foot Ulcer/drug therapy , Levofloxacin/therapeutic use , Pseudomonas aeruginosa/isolation & purification , Pseudomonas Infections/drug therapy , Keratoderma, Palmoplantar/diagnosis , Keratoderma, Palmoplantar/drug therapy , Microbial Sensitivity Tests/methods , Debridement/methodsABSTRACT
Pachydermodactyly is a type of benign digital fibromatoses, a rare condition that affects mostly young men. The cause is unknown but some authors suggest that traumatism can be involved. A 16-year-old man presented with symmetrical painless swellings on the fingers of both hands. He used to rub his fingers together. The control of living habits must be enphasized in order to avoid repeteated injuries. Hence, our consultation work is with the patient and his family. We describe a new case of pathology with a common clinical diagnosis, whose ignorance could lead us to carry out unnecesary tests involving inconvenience to the patient. It is important to emphasize the modification of the patient's living habits in order to achieve its improvement.